The Vioxx scandal, and the Food & Drug Administration’s (FDA) role in it, has not brought about much change at the agency, according to a new government report. Vioxx was approved for use in 1999, and quickly became a bestseller for Merck, with annual sales of $2.5 billion; however, the painkiller was pulled off the market [ ]
Vioxx Plaintiff Testifies About Illness
A postal worker who blames his heart attack on Vioxx took the stand Wednesday in the second product liability trial over the painkiller, describing in emotional testimony how he went from feeling "bulletproof" to unmanly after he was stricken.
No class-action status for federal Vioxx suits
A federal judge on Wednesday denied a motion for class-action status for personal injury and wrongful death cases involving Merck's withdrawn Vioxx painkiller.
Merck says Vioxx claimants will soon get checks
Merck & Co said on Thursday that more than 97 percent of eligible U.S. claimants had elected to participate in its $4.85 billion proposed Vioxx settlement, an adequate number to trigger funding of the program.
Contact:
Copyright © 2005 Vioxx Advisor.com All Rights Reserved